Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Change in Account Payables (2020 - 2025)

Oncology Institute (TOI) has disclosed Change in Account Payables for 6 consecutive years, with $439000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Account Payables fell 94.21% year-over-year to $439000.0, compared with a TTM value of $12.7 million through Sep 2025, up 32.34%, and an annual FY2024 reading of $9.2 million, up 82.22% over the prior year.
  • Change in Account Payables was $439000.0 for Q3 2025 at Oncology Institute, down from $6.4 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $7.6 million in Q3 2024 and bottomed at -$5.5 million in Q2 2024.
  • Average Change in Account Payables over 5 years is $1.2 million, with a median of $739000.0 recorded in 2024.
  • The sharpest move saw Change in Account Payables plummeted 725.11% in 2022, then soared 3508.57% in 2024.
  • Year by year, Change in Account Payables stood at -$3.3 million in 2021, then soared by 46.52% to -$1.8 million in 2022, then soared by 161.47% to $1.1 million in 2023, then tumbled by 32.57% to $739000.0 in 2024, then tumbled by 40.6% to $439000.0 in 2025.
  • Business Quant data shows Change in Account Payables for TOI at $439000.0 in Q3 2025, $6.4 million in Q2 2025, and $5.1 million in Q1 2025.